UVB phototherapy and skin cancer risk: A review of the literature

International Journal of Dermatology

Volumn 44, Issue 5, 2005, Pages 355-360

  Lee, Ernest ^a   Koo, John ^a   Berger, Tim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FINLAND; FOLLOW UP; GENITAL TRACT CANCER; GENITAL TRACT TUMOR; HUMAN; MEDICAL LITERATURE; MEDLINE; MELANOMA; PHOTOTHERAPY; PROSPECTIVE STUDY; PSORIASIS; PUVA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SKIN CANCER; ULTRAVIOLET B RADIATION; UNITED STATES;

HUMANS; RETINOIDS; RISK ASSESSMENT; SKIN NEOPLASMS; SKIN PIGMENTATION; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 18844413822     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02186.x     Document Type: Review

References (33)

1. Abeloff MD. Clinical Oncology, 2nd edn. New York: Churchill Livingstone, 2000: 2734-2735.
2. Clark C, Dawe RS, Evans AT, et al. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 2000; 136: 748-752.
3. Ramsey DL, Lish KM, Yalowitz CB, et al. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol 1992; 128: 931-933.
4. Milstein HJ, Vonderheid EC, Van Scott EJ, et al. Home ultraviolet phototherapy of early mycosis fungoides: preliminary observations. J Am Acad Dermatol 1982; 6: 355-362.
5. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
6. Pasker-de Jong PCM, Wielink G, van der Valk PGM, et al. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: a systematic review of the literature. Arch Dermatol 1999; 135: 834-840.
7. Studniberg HM, Weller P. PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 1993; 29: 1013-1022.
8. Maughan WZ, Muller SA, Perry HO, et al. Incidence of skin cancers in patients with atopic dermatitis treated with coal tar. J Am Acad Dermatol 1980; 3: 612-615.
9. Scotto J, Kopf AW, Urbach I. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974; 34: 1333-1338.
10. Pittelkow MR, Perry HO, Muller SA, et al. Skin cancer in patients with psoriasis treated with coal tar: a 25-year follow-up study. Arch Dermatol 1981; 117: 465-468.
11. Halprin KM, Comerford M, Taylor JR. Cancer in patients with psoriasis. J Am Acad Dermatol 1982; 7: 633-638.
12. Larko O, Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Suppl) (Stockh) 1982; 62: 507-512.
13. Bhate SM, Sharpe GR, Marks JM, et al. Prevalence of skin and other cancers in patients with psoriasis. Clin Exp Dermatol 1993; 18: 401-404.
14. Bajdik CD, Gallagher RP, Astrakianakis G, et al. Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Br J Cancer 1996; 73: 1612-1614.
15. Hannuksela-Svahn A, Pukkala E, Laara E, et al. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114: 587-590.
16. Stern RS, Laird N, Melski J, et al. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1982; 310: 1156-1161.
17. Stern RS, Khanh TN, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-1045.
18. Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet 1980; 1: 732-735.
19. Stern RS, Laird N. The carcinogenic risk of treatments of severe psoriasis. Cancer 1994; 73: 2759-2764.
20. Stern RS and Members of the Photochemotherapy Follow-up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation: the Photochemotherapy Follow-up Study. N Engl J Med 1990; 322: 1093-1097.
21. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of Nonmelanoma Skin Cancer in the United States (NIH Publication No. 83-2433). Bethesda, MD: National Cancer Institute, 1983.
22. Young JL Jr, Percy CL, Asire AJ, eds. Surveillance, Epidemiology, and End Results: Incidence and Mortality Data 1973-77. National Cancer Institute Monograph No. 57 (NIH Publication No. 81-2330). Washington DC: Government Printing Office, 1981.
23. Roush GC, Schymura MJ, Flannery JT. Secular and age distribution of scrotal cancer in Connecticut and a review of United States literature. Cancer 1984; 54: 596-601.
24. Maier H, Schemper M, Ortel B, et al. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 1996; 193: 185-191.
25. Elwood JM, Gallagher RP, Stapleton PJ. No association between malignant melanoma and acne or psoriasis: results from the Western Canada Melanoma Study. Br J Dermatol 1986; 115: 573-576.
26. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 2001; 45: 649-661.
27. Craven NM, Griffiths CEM. Retinoids in the management of non-melanoma skin cancer and melanoma. Cancer Survey 1996; 26: 267-288.
28. McKenna DB, Murphy GM. Skin cancer prophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999; 140: 656-660.
29. Van Weelden H, Baart de la Faille H, Young E, et al. A new development in UV-B phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
30. Flindt-Hansen H, Thune P, Larsen TE. The inhibiting effect of PABA on photocarcinogenesis. Arch Dermatol Res 1990; 282: 38-41.
31. Flindt-Hansen H, McFadden N, Eeg-Larsen T, et al. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol 1991; 71: 245-248.
32. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994; 10: 192-197.
33. Gibbs NK, Traynor NJ, MacKie RM, et al. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995; 104: 359-363.